Efalizumab Biosimilar(Anti-Integrin aL / ITGAL / CD11a Reference Antibody)

Biorbyt

Efalizumab Biosimilar(Anti-Integrin aL / ITGAL / CD11a Reference Antibody)

10

Research Use Only

Monoclonal

Unconjugated

Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the alpha subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research.

-20°C,2°C to 8°C

12352203